Enfusion, Inc.
ENFN · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $201,611 | $174,535 | $150,349 | $111,700 |
| % Growth | 15.5% | 16.1% | 34.6% | – |
| Cost of Goods Sold | $64,874 | $57,641 | $47,100 | $31,845 |
| Gross Profit | $136,737 | $116,894 | $103,249 | $79,855 |
| % Margin | 67.8% | 67% | 68.7% | 71.5% |
| R&D Expenses | $26,727 | $19,893 | $17,163 | $153,400 |
| G&A Expenses | $78,826 | $64,635 | $68,764 | $150,614 |
| SG&A Expenses | $103,855 | $85,053 | $98,050 | $202,339 |
| Sales & Mktg Exp. | $25,029 | $20,418 | $29,286 | $51,725 |
| Other Operating Expenses | $0 | $0 | -$638 | -$1,185 |
| Operating Expenses | $130,582 | $104,946 | $115,213 | $355,739 |
| Operating Income | $6,155 | $11,948 | -$11,964 | -$275,884 |
| % Margin | 3.1% | 6.8% | -8% | -247% |
| Other Income/Exp. Net | $1,234 | -$464 | -$225 | -$5,779 |
| Pre-Tax Income | $7,389 | $11,484 | -$12,189 | -$281,663 |
| Tax Expense | $4,566 | $2,231 | $1,074 | $579 |
| Net Income | $2,823 | $6,025 | -$13,263 | -$282,242 |
| % Margin | 1.4% | 3.5% | -8.8% | -252.7% |
| EPS | 0.019 | 0.1 | -0.16 | -4.3 |
| % Growth | -81.2% | 162.5% | 96.3% | – |
| EPS Diluted | 0.013 | 0.072 | -0.1 | -4.3 |
| Weighted Avg Shares Out | 92,045 | 88,202 | 85,393 | 65,583 |
| Weighted Avg Shares Out Dil | 129,550 | 129,429 | 132,648 | 65,583 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1,693 | $1,641 | $413 | $0 |
| Interest Expense | $0 | $0 | $0 | $4,594 |
| Depreciation & Amortization | $0 | $9,987 | $6,601 | $3,975 |
| EBITDA | $6,155 | $21,935 | -$5,363 | -$271,909 |
| % Margin | 3.1% | 12.6% | -3.6% | -243.4% |